1-4 of 4
Barbara Scappini, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The hOCT1 and ABCB1 Polymorphisms Don't Condition the Efficacy and Toxicity of Nilotinib As First-Line Treatment: An Italian Multicentric Experience

Sara Galimberti, MD PhD, Cristina Bucelli, MD, Elena Arrigoni, PhD, Claudia Baratè, Susanna Grassi, Federica Ricci, MD, Francesca Guerrini, PhD, Elena Ciabatti, PhD, Carmen Fava, MD, Antonio D'Avolio, Giulia Fontanelli, MD, Giovanna Rege Cambrin, MD, Alessandro Isidori, MD PhD, Federica Loscocco, PhD, Giovanni Caocci, MD, Marianna Greco, PhD, Monica Bocchia, MD, Lara Aprile, MD, Antonella Gozzini, MD, Barbara Scappini, MD, Daniele Cattaneo, MD, Giorgio La Nasa, MD, Alberto Bosi, MD, Mario Petrini, MD PhD, Pietro Leoni, MD, Romano Danesi, MD PhD, Giuseppe Saglio, MD PhD, Giuseppe Visani, MD, Agostino Cortellezzi, MD, Anna Rita Scortechini, MD, Alessandra Iurlo, MD, Antonello Di Paolo, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3951.
https://doi.org/10.1182/blood.V128.22.3951.3951
Published: 2016
Journal Articles

Auto-Reactive Glycosyl-Phosphatidyl-Inositol (GPI) Specific T Cells Are Present in Most Patients with Idiopathic Aplastic Anemia (IAA)

Lucia Gargiulo, PhD, Yoshitaka Zaimoku, MD, Barbara Scappini, MD, Hiroyuki Maruyama, MD, Rie Ohumi, Lucio Luzzatto, MD, Shinji Nakao, MD PhD, Rosario Notaro, MD
Journal: Blood
Blood (2015) 126 (23): 2409.
https://doi.org/10.1182/blood.V126.23.2409.2409
Published: 2015
Journal Articles

Efficacy of Low Dose Clofarabine Plus Intermediate Dose Cytarabine In An Unselected AML Refractory/Relapsed Adult Population

Claudio Romani, MD, Emanuele Angelucci, MD, Barbara Scappini, MD, Mario Petrini, MD, Martina Pettinau, Filippo Marmont, Francesco Caracciolo, Ernesta Audiosio, MD, Alberto Bosi
Journal: Blood
Blood (2010) 116 (21): 4349.
https://doi.org/10.1182/blood.V116.21.4349.4349
Published: 2010
Journal Articles

High Dose Cytarabine, Clofarabine and Gemtuzumab Ozogamicin (CLAC-MYL) in Relapsed or Refractory AML Patients.

Barbara Scappini, MD, Giacomo Gianfaldoni, MD, Palmieri Salvatore, MD, Maria Chiara Susini, MD, Teresa Izzo, MD, Francesco Mannelli, MD, Giovanni Longo, MD, Rosa Fanci, MD, Felicetto Ferrara, MD, Alberto Bosi, MD
Journal: Blood
Blood (2009) 114 (22): 1060.
https://doi.org/10.1182/blood.V114.22.1060.1060
Published: 2009